Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

July 1, 2024

Study Completion Date

August 1, 2024

Conditions
Community-acquired Pneumonia
Interventions
DRUG

Astaxanthin Oral Capsule

12 mg of astaxanthin oral capsule

DRUG

Placebo

starch placebo capsule

Trial Locations (1)

4650201

RECRUITING

Elmatarya Teaching Hospital, Cairo

All Listed Sponsors
lead

Future University in Egypt

OTHER